Article Details
Retrieved on: 2022-12-11 16:58:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... an immunomodulatory agent and an anti-CD38 monoclonal antibody.5 In August 2022, TECVAYLI™ received approval from the European Commission as ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here